Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens

INTRODUCTION: To simplify the medical treatment of glaucoma for patients on multiple drops by introducing brinzolamide/brimonidine tartrate fixed combination (BBFC) ophthalmic suspension 1%/0.2% (SIMBRINZA(®); Alcon Laboratories, Inc., Fort Worth, TX, USA) to the drop regimen and to establish its ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Moosavi, Reza, Ansari, Ejaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258589/
https://www.ncbi.nlm.nih.gov/pubmed/30367363
http://dx.doi.org/10.1007/s40123-018-0150-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258589/
https://www.ncbi.nlm.nih.gov/pubmed/30367363
http://dx.doi.org/10.1007/s40123-018-0150-x

Ejemplares similares